Skip to content

Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children

Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children in Assiut University Children Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03133169
Enrollment
80
Registered
2017-04-28
Start date
2017-06-01
Completion date
2019-08-26
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemolysis, Pulmonary Hypertension, Thalassemia in Children

Keywords

Thalassemia, Glutamine/glutamate ratio, Pulmonary hypertension

Brief summary

The study will investigate the relation between erythrocyte glutamine/glutamate ratio and pulmonary hypertension risk in Egyptian thalassemic children in Assiut University Children Hospital

Interventions

DIAGNOSTIC_TESTblood sample

blood sample for measuring liver and kidney function, CBC, ferritin level and erythrocyte glutamine level

DIAGNOSTIC_TESTTricuspid regurge velocity

Tricuspid regurge velocity will be measured by doppler echocardiography denoting the pulmonary hypertension risk in children

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Established diagnosis of Thalassemia. * PH risk documented by doppler echocardiography, defined as tricuspid regurge velocity (TRV) equal to or greater than 2.5 m/s

Exclusion criteria

* Acute crisis or hospitalization within 1 month of enrollment * Hepatic dysfunction (SGPT greater than 3X normal) * Renal dysfunction (Creatinine greater than 2X normal) * Patients on sildenafil (Viagra), calcium channel blockers or other drugs for the control of PH.

Design outcomes

Primary

MeasureTime frameDescription
Erythrocyte glutamine level2 monthsmarker for oxidative stress
Tricuspid regurge velocity2 monthsMeasures the risk of pulmonary hypertension

Secondary

MeasureTime frameDescription
Plasma glutamine level2 monthsAssess the glutamine level at each visit
Liver function tests2 monthsEvaluates the state of liver
Renal function tests2 monthsEvaluates the state of kidney
Ferritin level2 monthsmeasuring the iron overload

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026